SGB - Combined Solution of Bupivacaine + Ketamine Adjuvant for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Nov 2026: Trial registered, NCT07927036

The trials

NCT07927036: Enhancing the Effect of Stellate Ganglion Block in the Treatment of PTSD: Bupivacaine vs Bupivacaine + Ketamine

State
Not started
Phase
Phase 2
People
126 planned
Started
1 Feb 2027
Primary completion
1 Feb 2029
Arms
Group 2: One SGB injection combining standard local anesthetic, bupivacaine, with Ketamine
Results
None posted
  1. 9 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.